Diverticular DiseasesROLADINCT05829343
RObotic Versus LAparoscopic Colectomy for DIverticulitis.
An observational study of Diverticular Diseases and Diverticulitis, run by S.M. Misericordia Hospital at 1 site in Italy.
Trial summary
Over the last decade there has been a growing interest toward the application of robotic approach for diverticular disease. The evidence available on the literature showed that robotic approach, compared to the laparoscopic surgery, offers significant advantages in terms of conversion rate and shortened hospital stay… Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Diverticular Diseases, Diverticulitis
- What is being tested?
- Laparoscopic Left colectomy and Robotic left colectomy
- Type of treatment
- Surgery or procedure
- How many people
- 1,450 participants
- Where
- 1 siteItaly
- Study dates
- 1 Jun 2023to 30 Jun 2025
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Patients with diverticular disease of the left colon with surgical indication.
Who may be able to join
- Age > 18 years
- Elective or delayed urgency colorectal resection for left-sided DD
- Fully minimally invasive (robotic or laparoscopic) procedures.
Who cannot join
- Age < 18 years
- Urgent resection for DD
- Hybrid minimally invasive resection
- Conventional open resection.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Italy1 site, 1 recruiting
- Recruiting
Department of General and Emergency Surgery. Misericordia Hospital. Director: Coratti Andrea, MD
Grosseto, Tuscany, 58100
Giuseppe Giuliani, MD, 0039 3407356132, roladistudy@gmail.com
About this study
Official title: RObotic vs LAparoscopic Colectomy for DIverticulitis. A Multicenter Observational Prospective Study.
Over the last decade there has been a growing interest toward the application of robotic approach for diverticular disease. The evidence available on the literature showed that robotic approach, compared to the laparoscopic surgery, offers significant advantages in terms of conversion rate and shortened hospital stay for the treatment of diverticular disease.
The investigators aimed at evaluating whether robotic colectomy may offer some advantages over the laparoscopic approach for surgical treatment of diverticular disease by analyzing a one year multicenter prospective study.
Read more
Primary objective is to evaluate if robotic approach reduce the rate of conversion to open approach compared to laparoscopic surgery. Secondary objective is to assess difference between the two approaches in terms of rate of intraoperative complication, postoperative morbidities (according with Clavien and Dindo Classification), hospital stay and at one year follow up. Inclusion criteria are: elective colectomy for complicated or non-complicated diverticular disease performed with laparoscopic or robotic approach and age between 18 and 90 years. Exclusion criteria are non-elective colectomy (emergency resection), open procedure, diverticular resection performed during other procedure (i.e. colectomy for cancer). Data will be collected in one year from the start of the study.
Due to the lack of available evidence, it is impossible to draw definitive conclusions. With this study, the investigators hope to clarify the role of the robotic approach in the treatment of diverticular disease.
Read the detailed description
Background Over the past decade, there has been a growing interest in the use of robotic surgery for diverticular disease (DD). The evidence available in the literature is based on retrospective studies and two meta-analyses1,2. To date, the robotic approach offers significant advantages over laparoscopic surgery in terms of conversion rate and shortened hospital stay for the treatment of diverticular disease.
The investigators aimed to evaluate whether elective robotic colectomy may offer some advantages over the laparoscopic approach for surgical treatment of diverticular disease performing a prospective multicenter study.
Methods and Materials This is a multi-center, prospective, not-for-profit cohort study that will enroll patients undergoing elective or delayed urgent surgical treatment for left-sided colonic diverticular disease. The enrollment period will be one year, followed by one year of follow-up. The study will start in Juin 2023.
Data will be collected in a prospective database using an easy to fill out Google form, also available on mobile devices.
Several preoperative, intraoperative and postoperative outcomes will be analyzed.
OUTCOMES Pre-Operative
- Demographic Outcomes: Age, gender, body mass index (BMI), American Society of Anesthesiologists (ASA), Charlson Comorbidity Index (CSI: https://www.mdcalc.com/calc/3917/charlson-comorbidity-index-cci)
- Indications for surgery:
- Complicated DD: colonic stenosis, abscess, fistula, others;
- Recurrent DD: multiple episodes of diverticulitis affecting quality of life;
- Planned vascular ligation (inferior mesenteric artery vs. sigmoid arteries)
- Preoperative bowel preparation
- Indication for minimally invasive approach pursued (Why Rob vs Lap)
Intraoperative
- Surgical approach (laparoscopic or robotic)
- Intraoperative findings (sigmoid stenosis, stricture, adhesion, fistula)
- Intraoperative complications (specify types)
- Conversion to open approach
- Operative times
- Effective vessel ligation
- Splenic flexure mobilization
- Type of colon resection (sigmoidectomy, left colectomy, anterior rectal resection, Hartmann procedure)
- Stoma (ileostomy vs. colostomy)
- Associated procedures
- Specimen extraction (midline, off midline, suprapubic or natural orifice) Postoperative
- 30-day postoperative complications (Clavien-Dindo classification)
- 30-day reoperation
- 30-day readmission
- Length of stay LOS
- Time to return to work (days)
- 30 days - Mortality
- One-year follow-up
Sample size The estimated sample sizes for the study using a proportion of 0.125 for Laparoscopic approach and a proportion of 0.074 for Robotic approach, and a risk of conversion rate OR=0.56 (IC95% 0.45-0.70), is at least 1450 patients (725 for the group - alpha = 0.0500, power = 0.9000, delta = 0.5600). MICE (Multivariate Imputation via Chained Equations) is the procedure used to impute missing data for explanatory variables. In this approach, instead of imputing all missing values with a single value (mean/median), the statistical information is derived from the median), it takes into account the statistical information derived from the distribution of the other variables. The missing values are considered as an outcome to be predicted. This allows to take into account the correct variability in the entire data set and to obtain estimates that are as unbiased as possible.
Statistical Analysis The quantitative variables included in the study are expressed as mean ± standard deviation, median and range (distance between maximum and minimum values), both at the overall level and by surgical approach. The qualitative (categorical) variables are presented as percentages and absolute values, both at a general level and divided by surgical approach. It will be evaluated, if necessary, to perform a propensity score matching procedure between the two approaches (Rob and Lap), using the nearest neighbor matching technique, without replacement. Demographics, pre-operative and intra-operative characteristics are used in the propensity score logistic regression models to minimize selection bias, by assembling a matched cohort in which confounding factors are balanced between the two groups. In the matched cohort bivariate analyses are performed to .compare the primary and secondary outcomes between the two groups.
The comparison between the quantitative variables of interest is performed by the two-tailed Student T-test (in case of heteroskedasticity of variances) or with nonparametric tests, such as the Mann-Whitney U test or theKruskal-Wallis test. The comparison between qualitative variables of interest is carried out to evaluate the association or not between them, through an extension of the chi-square test suitable for multicenter studies (the Cochran - Mantel - Haenszel test).
For the entire cohort multivariate logistic regression models are performed to test the effect of surgical approach on primary and secondary outcomes.
Ethics and dissemination The trial will be conducted in accordance with the Declaration of Helsinki and in compliance with the Good Clinical Practice, Principle E6 (R2). The study will be approved by the Ethics Committee of the coordinating center (Comitato Etico di Area Vasta Sud Est Dipartimento Politiche del Farmaco e Attività Farmaceutiche Segreteria Amministrativa) and then will be registered at ClinicalTrial.gov. Subsequently, all participating centers will receive approval to participate from the local institutional review board. Authorship for written publications will be confirmed for all participating investigators (2 investigators per center). Anonymized participant-level data sets will be made available upon reasonable upon reasonable request by contacting the principal investigator. Study results will be presented at international or national meetings and published in surgical journals.
- Conditions
- Diverticular Diseases, Diverticulitis
- Being tested
- Laparoscopic Left colectomy, Robotic left colectomy
- Keywords
- Diverticular Disease, Robotic surgery, Laparoscopic surgery, Minimal invasive surgery, Colorectal surgery
- Medical subject headings
- Diverticular Diseases, Diverticulitis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Laparoscopic Left colectomyProcedure or surgery
Patients are treated with a laparoscopic approach as the standard of care for the treatment of left-sided colonic diverticular disease, depending on the experience of the surgeon or institution.
Robotic left colectomyProcedure or surgery
Patients are treated with a robotic approach as the standard of care for the treatment of left-sided colonic diverticular disease, depending on the experience of the surgeon or institution.
| Study group | Role | What they receive |
|---|---|---|
| Robotic surgery group | Patients with diverticular disease resected with a robotic approach. Receives: Procedure: Robotic left colectomy | |
| Laparoscopic surgery group | Patients with diverticular disease resected with a laparoscopic approach. Receives: Procedure: Laparoscopic Left colectomy |
What is being measured
The primary outcome is the main question the study is designed to answer.
Conversion rate
The primary objective is to evaluate whether the robotic approach reduces the rate of conversion to open surgery compared to laparoscopic surgery.
Measured: One year
Secondary outcomes (9)
Intra - operative complications
The first secondary outcome measure is to assess the difference between the two approaches in terms of intra-operative complications (e.g. bleeding, spleen injury, ureteral injury, bowel perforation)
Measured: One year
Operative time
Evaluate the possible difference in terms of operative time (expressed in minutes) between the two groups, to assess whether the robotic approach has a longer operative time than the laparoscopic approach.
Measured: One year
Complicated disease
Evaluate the difference between the two approaches in the number of complicated cases performed. For example, analyze whether one group performs more complicated diverticular disease (e.g., colonic stenosis, colorectal fistula, intraperitoneal abscess) than the other.
Measured: One year
30 day Post - operative complications
Another secondary outcome measure is to assess the difference between the two groups in terms of post-operative complications (using the Clavien and Dindo classification).
Measured: One year
30-day Post - operative re-operation
Evaluate the possible difference in term of rate of re-operation between the two groups within 30 day after surgery.
Measured: One year
30-day Post - operative mortality
Evaluate the possible difference in term of rate of mortality between the two groups within 30 day after surgery.
Measured: One year
Length of hospital stay
Evaluate the possible difference in term of length of hospital stay (expressed in day) between the two groups.
Measured: One year
Time to return at work
Evaluate the possible difference in time to return to work (expressed in days from surgery) between the two groups.
Measured: One year
One year follow up
Evaluate the possible difference in terms of disease recurrence or incisional hernia, between the two groups at one year after surgery.
Measured: Two years
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted25 Apr 2023
- Study start1 Jun 2023
- Primary completion30 Mar 2025 (estimated)
- Study completion30 Jun 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for Diverticular DiseasesStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 1,450 participants (estimated)
Sponsor and investigators
- Lead sponsor
- S.M. Misericordia Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Giuliani Giuseppe, S.M. Misericordia Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05829343
- Sponsor's protocol ID
- ROLADI - 1.0
- Acronym
- ROLADI
- Status last verified
- Jan 2025
- First submitted
- 11 Apr 2023
- Last updated
- 29 Jan 2025
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Giuliani G, Guerra F, Coletta D, Giuliani A, Salvischiani L, Tribuzi A, Caravaglios G, Genovese A, Coratti A. Robotic versus conventional laparoscopic technique for the treatment of left-sided colonic diverticular disease: a systematic review with meta-analysis. Int J Colorectal Dis. 2022 Jan;37(1):101-109. doi: 10.1007/s00384-021-04038-x. Epub 2021 Oct 1.
PubMed 34599362Larkins K, Mohan H, Apte SS, Chen V, Rajkomar A, Larach JT, Smart P, Heriot A, Warrier S. A systematic review and meta-analysis of robotic resections for diverticular disease. Colorectal Dis. 2022 Oct;24(10):1105-1116. doi: 10.1111/codi.16227. Epub 2022 Aug 9.
PubMed 35723895
Study at a glance
From the registry record, last updated by the sponsor on 29 Jan 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- RObotic vs LAparoscopic Colectomy for DIverticulitis. A Multicenter Observational Prospective Study.
- ClinicalTrials.gov ID
- NCT05829343
- Acronym / sponsor ID
- ROLADI / ROLADI - 1.0
- Conditions
- Diverticular Diseases, Diverticulitis
- Keywords
- Diverticular Disease, Robotic surgery, Laparoscopic surgery, Minimal invasive surgery, Colorectal surgery
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 1,450 participants (estimated)
- Lead sponsor
- S.M. Misericordia HospitalUniversity, hospital or other
- Study start
- 1 Jun 2023 (actual)
- Primary completion
- 30 Mar 2025 (estimated)
- Study completion
- 30 Jun 2025 (estimated)
- First posted
- 25 Apr 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Over the last decade there has been a growing interest toward the application of robotic approach for diverticular disease. The evidence available on the literature showed that robotic approach, compared to the laparoscopic surgery, offers significant advantages in terms of conversion rate and shortened hospital stay for the treatment of diverticular disease.
The investigators aimed at evaluating whether robotic colectomy may offer some advantages over the laparoscopic approach for surgical treatment of diverticular disease by analyzing a one year multicenter prospective study.
Primary objective is to evaluate if robotic approach reduce the rate of conversion to open approach compared to laparoscopic surgery. Secondary objective is to assess difference between the two approaches in terms of rate of intraoperative complication, postoperative morbidities (according with Clavien and Dindo Classification), hospital stay and at one year follow up. Inclusion criteria are: elective colectomy for complicated or non-complicated diverticular disease performed with laparoscopic or robotic approach and age between 18 and 90 years. Exclusion criteria are non-elective colectomy (emergency resection), open procedure, diverticular resection performed during other procedure (i.e. colectomy for cancer). Data will be collected in one year from the start of the study.
Due to the lack of available evidence, it is impossible to draw definitive conclusions. With this study, the investigators hope to clarify the role of the robotic approach in the treatment of diverticular disease.
Detailed description
Background Over the past decade, there has been a growing interest in the use of robotic surgery for diverticular disease (DD). The evidence available in the literature is based on retrospective studies and two meta-analyses1,2. To date, the robotic approach offers significant advantages over laparoscopic surgery in terms of conversion rate and shortened hospital stay for the treatment of diverticular disease.
The investigators aimed to evaluate whether elective robotic colectomy may offer some advantages over the laparoscopic approach for surgical treatment of diverticular disease performing a prospective multicenter study.
Methods and Materials This is a multi-center, prospective, not-for-profit cohort study that will enroll patients undergoing elective or delayed urgent surgical treatment for left-sided colonic diverticular disease. The enrollment period will be one year, followed by one year of follow-up. The study will start in Juin 2023.
Data will be collected in a prospective database using an easy to fill out Google form, also available on mobile devices.
Several preoperative, intraoperative and postoperative outcomes will be analyzed.
OUTCOMES Pre-Operative
- Demographic Outcomes: Age, gender, body mass index (BMI), American Society of Anesthesiologists (ASA), Charlson Comorbidity Index (CSI: https://www.mdcalc.com/calc/3917/charlson-comorbidity-index-cci)
- Indications for surgery:
- Complicated DD: colonic stenosis, abscess, fistula, others;
- Recurrent DD: multiple episodes of diverticulitis affecting quality of life;
- Planned vascular ligation (inferior mesenteric artery vs. sigmoid arteries)
- Preoperative bowel preparation
- Indication for minimally invasive approach pursued (Why Rob vs Lap)
Intraoperative
- Surgical approach (laparoscopic or robotic)
- Intraoperative findings (sigmoid stenosis, stricture, adhesion, fistula)
- Intraoperative complications (specify types)
- Conversion to open approach
- Operative times
- Effective vessel ligation
- Splenic flexure mobilization
- Type of colon resection (sigmoidectomy, left colectomy, anterior rectal resection, Hartmann procedure)
- Stoma (ileostomy vs. colostomy)
- Associated procedures
- Specimen extraction (midline, off midline, suprapubic or natural orifice) Postoperative
- 30-day postoperative complications (Clavien-Dindo classification)
- 30-day reoperation
- 30-day readmission
- Length of stay LOS
- Time to return to work (days)
- 30 days - Mortality
- One-year follow-up
Sample size The estimated sample sizes for the study using a proportion of 0.125 for Laparoscopic approach and a proportion of 0.074 for Robotic approach, and a risk of conversion rate OR=0.56 (IC95% 0.45-0.70), is at least 1450 patients (725 for the group - alpha = 0.0500, power = 0.9000, delta = 0.5600). MICE (Multivariate Imputation via Chained Equations) is the procedure used to impute missing data for explanatory variables. In this approach, instead of imputing all missing values with a single value (mean/median), the statistical information is derived from the median), it takes into account the statistical information derived from the distribution of the other variables. The missing values are considered as an outcome to be predicted. This allows to take into account the correct variability in the entire data set and to obtain estimates that are as unbiased as possible.
Statistical Analysis The quantitative variables included in the study are expressed as mean ± standard deviation, median and range (distance between maximum and minimum values), both at the overall level and by surgical approach. The qualitative (categorical) variables are presented as percentages and absolute values, both at a general level and divided by surgical approach. It will be evaluated, if necessary, to perform a propensity score matching procedure between the two approaches (Rob and Lap), using the nearest neighbor matching technique, without replacement. Demographics, pre-operative and intra-operative characteristics are used in the propensity score logistic regression models to minimize selection bias, by assembling a matched cohort in which confounding factors are balanced between the two groups. In the matched cohort bivariate analyses are performed to .compare the primary and secondary outcomes between the two groups.
The comparison between the quantitative variables of interest is performed by the two-tailed Student T-test (in case of heteroskedasticity of variances) or with nonparametric tests, such as the Mann-Whitney U test or theKruskal-Wallis test. The comparison between qualitative variables of interest is carried out to evaluate the association or not between them, through an extension of the chi-square test suitable for multicenter studies (the Cochran - Mantel - Haenszel test).
For the entire cohort multivariate logistic regression models are performed to test the effect of surgical approach on primary and secondary outcomes.
Ethics and dissemination The trial will be conducted in accordance with the Declaration of Helsinki and in compliance with the Good Clinical Practice, Principle E6 (R2). The study will be approved by the Ethics Committee of the coordinating center (Comitato Etico di Area Vasta Sud Est Dipartimento Politiche del Farmaco e Attività Farmaceutiche Segreteria Amministrativa) and then will be registered at ClinicalTrial.gov. Subsequently, all participating centers will receive approval to participate from the local institutional review board. Authorship for written publications will be confirmed for all participating investigators (2 investigators per center). Anonymized participant-level data sets will be made available upon reasonable upon reasonable request by contacting the principal investigator. Study results will be presented at international or national meetings and published in surgical journals.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Robotic surgery group | – | Procedure: Robotic left colectomyPatients with diverticular disease resected with a robotic approach. |
| Laparoscopic surgery group | – | Procedure: Laparoscopic Left colectomyPatients with diverticular disease resected with a laparoscopic approach. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Patients with diverticular disease of the left colon with surgical indication.
Key inclusion criteria (3 listed)
- Age > 18 years
- Elective or delayed urgency colorectal resection for left-sided DD
- Fully minimally invasive (robotic or laparoscopic) procedures.
Key exclusion criteria (4 listed)
- Age < 18 years
- Urgent resection for DD
- Hybrid minimally invasive resection
- Conventional open resection.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Laparoscopic Left colectomyPatients are treated with a laparoscopic approach as the standard of care for the treatment of left-sided colonic diverticular disease, depending on the experience of the surgeon or institution. | Procedure or surgery | Laparoscopic surgery group |
| Robotic left colectomyPatients are treated with a robotic approach as the standard of care for the treatment of left-sided colonic diverticular disease, depending on the experience of the surgeon or institution. | Procedure or surgery | Robotic surgery group |
Primary outcome
Conversion rate
Time frame: One year
The primary objective is to evaluate whether the robotic approach reduces the rate of conversion to open surgery compared to laparoscopic surgery.
9 secondary outcomes
Intra - operative complications
Time frame: One year
Operative time
Time frame: One year
Complicated disease
Time frame: One year
30 day Post - operative complications
Time frame: One year
30-day Post - operative re-operation
Time frame: One year
30-day Post - operative mortality
Time frame: One year
Length of hospital stay
Time frame: One year
Time to return at work
Time frame: One year
One year follow up
Time frame: Two years
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 29 Jan 2025.
- Results publication: PubMed 34599362Giuliani G, Guerra F, Coletta D, Giuliani A, Salvischiani L, Tribuzi A, Caravaglios G, Genovese A, Coratti A. Robotic versus conventional laparoscopic technique for the treatment of left-sided colonic diverticular disease: a systematic review with meta-analysis. Int J Colorectal Dis. 2022 Jan;37(1):101-109. doi: 10.1007/s00384-021-04038-x. Epub 2021 Oct 1.
- Results publication: PubMed 35723895Larkins K, Mohan H, Apte SS, Chen V, Rajkomar A, Larach JT, Smart P, Heriot A, Warrier S. A systematic review and meta-analysis of robotic resections for diverticular disease. Colorectal Dis. 2022 Oct;24(10):1105-1116. doi: 10.1111/codi.16227. Epub 2022 Aug 9.
- Individual participant dataSharing planned: No
Related trials for Diverticular Diseases
Active, not recruiting
Virtual Incision Robotically Assisted Surgical Device Use in Minimally Invasive Colectomy
Colon Cancer, Colon Polyp
Not yet recruitingObservational study
Analysis of the Role of the Microbiota in Diverticular Disease
Diverticular Disease of Colon, Acute Diverticulitis
Recruiting
Initial Safety of SFM Plus OTOLoc for Creating Side-to-side or End-to-side Colorectal Anastomoses
Colorectal Cancer, Diverticular Diseases
RecruitingObservational study
Quality of Life and Surgery in Diverticular Disease
Diverticulitis Colon, Quality of Life
Active, not recruitingEarly Phase 1
FMT in Uncomplicated Diverticulitis
Diverticulitis, Uncomplicated Diverticular Disease
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Department of General and Emergency Surgery. Misericordia Hospital. Director: Coratti Andrea, MD
Grosseto, Italy
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Diverticular Diseases and Diverticulitis, run by S.M. Misericordia Hospital at 1 site in Italy.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 29 Jan 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Conversion rate (time frame: One year). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT05829343, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Jan 2025; AzTrials last refreshed its copy on 27 Oct 2026.